ADVANCINGWITH PURPOSE
INTEGRATED ONCOLOGY PROGRAMANNUAL REPORT WITH STATISTICAL DATA FROM 2016
2017 marked another year of significant growth
and achievement for DuPage Medical Group (DMG).
As DMG continues to expand its reach and provide
care in new communities, our focus remains
centered on delivering comprehensive, innovative
and personalized care through the use of leading-
edge technology, the latest medical advancements
and collaboration among our healthcare providers
to develop individualized treatment plans. Since its
inception in 2013, the program has grown from
1,300 cases to 2,800 cases in 2017. DMG also remains
focused on providing a seamless patient experience
and is dedicated to ongoing expansion of care
and support resources we offer our patients; our
integrated oncology program is no exception.
In 2017, during the program’s fourth year, we were
able to provide even greater access to care by
expanding our services to meet the needs of patients
spanning the west and southwest suburbs with more
specialties and services offered in both Will and
Suburban Cook Counties. The Integrated Oncology
Program is comprised of board certified physicians
who specialize in medical and radiation oncology
and partner with a number of specialists to provide a
broad range of oncology services. Specialties include
dermatology, endocrinology, gastroenterology,
gynecology, otolaryngology, pathology, plastic
surgery, pulmonary, radiology, surgery and urology.
Working together, the multi-disciplinary physician-led
teams have continued to make a high impact on our
patients and their families.
Throughout our patients’ cancer journeys, we help
them navigate the entire treatment process and
offer resources and encouragement every step of
the way. From screening and diagnosis, to treatment
and recovery support, DMG’s Integrated Oncology
Program provides comprehensive care for all types
of cancer. DMG also continues to invest in technology
to aid in the most accurate diagnoses and treatment
options available. Through our partnerships, we are
able to provide access to the latest clinical trials,
emerging treatments, and adapt to the ever-
changing needs of our patients.
In 2015, DuPage Medical Group’s Integrated Oncology
Program was awarded a nationally-recognized
accreditation based on our continued commitment
to quality, access and exceptional patient outcomes.
In 2017, we are proud to still be the only accredited
Freestanding Cancer Center in Illinois, a distinction
received by the Commission on Cancer of the
American College of Surgeons.
ADVANCING CARE THROUGH COLLABORATION, INNOVATION & PERSONALIZATION
ANNUAL REPORT WITH STATISTICAL DATA FROM 2016
A YEAR IN
REVIEW
Expanding the oncology services in the south suburbs to now include 3D mammography at our Tinley Park location. Providing more robust radiology services including, but not limited to, CT, digital mammography and MRI in our new Bloomingdale location.
Growing our team of skilled medical oncology providers who support the Integrated Oncology Program, including board certified physicians, physician assistants, nurse practitioners and nurse navigators.
Launching our Robotic Surgery Program, comprised of more than 25 highly skilled general surgeons, gynecologists, otolaryngologists and urologists who specialize in robotic-assisted procedures, including complex cancer-related surgeries to achieve the best possible patient outcomes.
Collaborating with Myriad® to launch a telegenetics program in July, which provides access to free genetic testing for oncology and high-risk patients at our Winfield and Lisle locations.
Expanding online scheduling capabilities to nearly all Integrated Oncology Program providers, specialists and diagnostic services through MyChart.
Continuing to offer community cancer prevention sessions and educational seminars, including skin cancer screenings and nutrition workshops for oncology patients.
Offering free smoking cessation classes to patients and community members, including classes in the south suburbs at our Tinley Park location.
Supporting our community partners with grants and volunteers totaling more than $150,000 in 2017.
In 2017, DuPage Medical Group continued to build upon its
Integrated Oncology Program to provide the best care
to its patients by:
DMG’s Integrated Oncology Program is accredited
by the Commission on Cancer of the American
College of Surgeons and provides exceptional
cancer care, from screening and diagnosis, to
treatment, recovery and survivorship.
The program consists of a multidisciplinary
team comprised of physicians skilled in medical
oncology, radiation oncology, radiology and
numerous surgical specialties who work together
with specialists across DuPage Medical Group to
offer patients comprehensive and individualized
treatment plans.
Our team of providers utilizes state-of-the-
art, highly accurate equipment and advanced
treatment techniques to provide the best possible
care for our oncology patients. DMG was the
first organization in the western suburbs to offer
3D mammography, the latest in breast imaging
technology, and expanded this service to most of
its Chicagoland area radiology locations, including
our Tinley Park location, to serve the communities
in the south suburbs.
Access to other cancer-related services is available
throughout Suburban Chicagoland at multiple
locations, with the program’s hub at the Lisle
Medical Office Building. Many DMG offices offer
on-site lab and radiology services for a more
convenient patient experience.
DMG’s academic affiliation with Rush University
Medical Center provides further resources to
patients by bringing university-level, sub-specialty
care to the suburbs.
Why choosethe DMG Integrated Oncology Program?
Your Second Opinion
Cancer Conferences are highly valuable tools that allow
our physicians to educate and become educated on new
or best treatment options and protocols, participate in
multidisciplinary planning and promote collaboration
among physicians and medical staff. The National
Comprehensive Cancer Network® (NCCN) guidelines
require 15 percent of cancer cases be presented. In 2016,
DMG specialists presented more than 20 percent of their
annual cases, surpassing national standards. The specialty
conferences represent major cancer diagnosis at DMG,
including breast, genitourinary system, digestive system,
lung/chest, hematologic, head/neck cancers, skin and
soft tissue malignancies.
In 2017, in an effort to continue to meet the needs of our
growing service area and engage new DMG providers
in the Integrated Oncology Program, a general cancer
conference was launched for providers in the south service
area on October 12th. The south cancer conferences are
held on the second Thursday of every month in Tinley Park
and feature case review of all cancer types.
Patient communication is also an important part of the
cancer conferences. Patients are informed when their case
will be presented during our weekly cancer conferences
for multidisciplinary input. Following the conference, the
managing physician communicates the group consensus
to the patient.
Cancer CONFERENCES
Specialty Cancer Conferences | 2016
percentage of cases presented by cancer type
BREAST
UROLOGIC
LUNG
DIGESTIVE TRACT
HEMATOLOGIC
HEAD & NECK/THYROID
SKIN & SOFT TISSUE
Female
Breast
Lung & Bronchus
Thyroid
Colon & Rectum
Melanoma of the Skin
Non - Hodgkin Lymphoma
Uterine Corpus
Leukemia
Kidney & Renal Pelvis
Ovary
All Other Sites
Male
Prostate
Melanoma of the Skin
Lung & Bronchus
Colon & Rectum
Urinary Bladder
Kidney & Renal Pelvis
Pancreas
Leukemia
Oral Cavity & Pharynx
All Other Sites
# of cases (%)
539 (47%)
90 (8%)
84 (7%)
76 (7%)
76 (7%)
39 (3%)
22 (2%)
22 (2%)
14 (1%)
8 (1%)
171 (15%)
New Cancer Incidence by Gender & Site | 2016
# of cases (%)
371 (34%)
109 (10%)
85 (8%)
85 (8%)
69 (6%)
34 (3%)
32 (3%)
27 (3%)
23 (2%)
203 (19%)
22%
22%
20%
13%
9%
8%
6%
DuPage Medical Group’s board-certified oncologists
and hematologists provide a wide range of services
in a caring and comfortable environment at six
convenient locations. Our specialists manage
chronic and acute non-malignant blood disorders,
leukemia and lymphoma and solid tumor treatments.
Our physicians keep current in changes in clinical
advancements and NCCN guidelines.
In the oncology specialty, Advanced Practice
Providers (APP), including Nurse Practitioners
(NP) and Physician Assistants (PA), are part of the
interdisciplinary team that develops plans for active
cancer treatment and post treatment care. Our APPs
collaborate with physicians to determine treatment
decisions. They perform inpatient rounds, follow-up
visits, symptom management, survivorship care, end-
of-life care and providing non-cancer-related primary
care to help improve patient outcomes.
In 2016, DMG added to our APPs by bringing on a
team of highly-skilled Advanced Nurse Practitioners
(APN) to help meet the growing demands. Since
joining the program, our APNs have played an
instrumental role in providing exceptional care to
our patients and work closely with our physicians
and other support staff, including infusion nurses and
nurse navigators.
DMG’s compassionate nurse navigators offer
medical guidance and support and walk the patient
and their family through the cancer treatment
process. Our skilled nurses are certified through the
Oncology Nursing Certification Corporation (ONCC),
highlighting our commitment to employing highly
knowledgeable nurses with advanced expertise to
provide care for our patients.
Infusion Center services are integral to our cancer
program. Our numerous infusion centers are staffed
with certified chemotherapy and biotherapy
providers, who are specially trained to administer
all chemo-toxic drugs and monitor patients while
in treatment. All patients receive a customized
treatment plan for their infusion needs and their
care is monitored by dedicated nurses every step
of the way. Additionally, on-site lab services are
available at each location. To enhance our infusion
patient experience, we have a clinical pharmacist
that oversees the dosing and administration of all
medications infused.
Clinical pharmacists (PharmD)
specializing in oncology practice
provide pharmacy services to
patients by overseeing treatment
plans (per NCCN Guidelines)
for accuracy and completeness
and ensuring delivery of the
highest quality patient care. They
collaborate with physicians and
advanced practice providers and
recommend adjustments to drug
therapy based on clinical status
and treatment outcomes. They
also coordinate with the clinical
team to ensure all aspects of
pharmaceutical care are delivered
in a safe and timely manner.
In addition to supervising certified
pharmacy technicians, the clinical
pharmacist coordinates workflow
and acts as a resource for patient
and staff education. Our on-site
pharmacists help to increase
the safety and efficacy of
prescribed chemotherapies. The
pharmacists calculate appropriate
chemotherapy doses based
on body surface area, weight
and renal function and assess
possible drug interactions and
contraindications to therapy.
This quality initiative reflects
the highest level of integrated,
patient-centered care.
DMG has the highest commitment
to advanced technology and
continues to demonstrate this by
using a closed-system transfer
device (CSTD).
Oncology pharmacists oversee
the preparation of chemotherapy
in United States Pharmacopeia
797/800-approved clean rooms
where sterile infusion mixtures
are processed. This process
significantly reduces the
chance of exposure
to hazardous
materials.
DMG also has on-site retail
Pharmacies in Lisle, Tinley
Park, and Blue Island. Each
pharmacy is aligned with the
oncology department financial
counselor and the national
Patient Assistance Network to
help patients gain access to
drug assistance if necessary, and
to ensure their out-of-pocket
expense is as low as possible.
Retail pharmacies are staffed with
pharmacists (PharmD) who work
with prior authorizations, appeal
letters and co-pay programs
to assist with all oncology and
specialty medications.
Our highly specialized care team
has implemented a clinical quality
program aimed at antiemetic
schedules. Revised antiemetic
schedules have been adapted
to all chemotherapy patients’
profiles based on standards from
the Multinational Association
of Supportive Care in Cancer
(MASCC). We utilize the MASCC
screening tool to evaluate the
effectiveness of our antiemetic
regimens. Based on analysis, we
translate those outcomes into
improved patient care and better
quality of life for patients during
treatment.
The Hematologic Malignancy program at DuPage
Medical Group provides comprehensive, patient-
centered care for adult patients diagnosed with
leukemias, myelodyplastic syndromes, lymphomas,
myeloma and other blood-related malignancies. The
team is led by hematology/medical oncologists who
collaborate with radiation oncologists, pathologists,
radiologists, advanced practice providers and nurse
navigators to provide individualized care to our
patients. Diagnostic tests may include blood tests,
bone marrow aspiration and biopsy, lumbar puncture
to collect spinal fluid, lymph node biopsy or lymph
node removal.
Once the diagnosis is made, the physician may need
to determine the stage of cancer via chest X-ray, CT,
PET/CT or MRI. Our multidisciplinary team takes into
account many factors when developing individualized
care plans including the stage of cancer, overall
health and ability to withstand therapy. Treatment
options may include chemotherapy, radiation
therapy, blood or bone marrow transplantation,
biological therapy, immunotherapy or combination
therapies. Our program allows seamless transition to
one of the area’s best blood and marrow transplant
programs.
Medical Oncology & Infusion SERVICES
Hematologic Malignancies
Pharmacy SERVICES
Since 2013, DMG Radiation Oncology services
have grown to offer patients access to more
advanced services. Our team continues to provide
exceptional patient care, utilizing state-of-the-
art stereotactic radiosurgery used to target both
intra-cranial and extracranial lesions, as well as
a variety of techniques used to treat all other
body sites. This technology allows us to provide
treatment with unparalleled ease, precision,
accuracy and speed.
For those receiving intra-cranial radiation, DMG
physicians offer a frameless approach. Without
sacrificing accuracy, this technique allows patients
to remain in a less confined position, easing fears
of claustrophobia during the highly complex
procedure. Accomplished through the use of
Vision RT, which is an optical surface monitoring
system (OSMS), infrared lights are used to monitor
thousands of points across a patient’s body to
aid in positioning before treatment and track
movement during treatment delivery. Software
allows for interruption of the treatment if a
patient moves outside of a tightly set tolerance
to ensure that radiation is only delivered to the
exact location of the tumor. OSMS is also used in
radiation oncology to offer an advanced approach
to patients with left side breast cancers.
In cases where patient anatomy is less than
favorable, DMG radiation oncologists apply an
innovative technique called Deep Inspiration
Breath-Hold (DIBH). By having patients take a
deep breath prior to initiating treatment, radiation
oncologists can increase the distance between
the breast and the heart, preserving healthy
heart tissue. Using OSMS in these cases ensures
that treatment is only delivered when patients
are perfectly aligned and have taken the correct
amount of air into the lung.
In addition to the external beam radiation therapy
services, DMG proudly offers access to high-
dose rate (HDR) brachytherapy radiation. HDR
brachytherapy allows for high doses of radiation
to be accurately delivered to more localized areas
of disease by using a small radioactive source.
This service is offered for a variety of body sites,
including gynecological, breast and skin. For skin
lesions, radiation is applied at the skin surface
allowing the radiation to target only the area of
interest with minimal dose to surrounding skin
and underlying tissue. For both gynecological
and breast cancers, HDR brachytherapy is
delivered by specialized applicators that allow
the HDR brachytherapy source to deliver radiation
internally to the area of disease.
This technique can be used in lieu of external
beam radiation therapy or as a supplemental
technique to boost areas of high risk depending
on patient disease characteristics. HDR
brachytherapy for breast cancer, also known as
accelerated partial breast irradiation (APBI), is
a special service offered to qualifying patients.
This technique brings together specialists from
both surgery and radiation oncology to deliver
radiation locally to the lumpectomy bed over a
five-day period, compared to the standard three
to five-week course of radiation, while sparing
healthy breast tissue.
Radiation therapy also plays an important
treatment role for many breast cancer patients.
Radiation oncologists, physicists, radiation
therapists and nurses use their specialized skills
to provide the most accurate treatment available.
Treatment methods include HDR brachytherapy,
prone breast radiation and accelerated partial
breast irradiation. The deep inspiration breath
hold technique can also be used for left-sided
breast cancer patients.
From the advanced technologies and treatment
techniques offered, to the compassionate staff
members that help guide our patients through
their cancer journeys; our physicians lead a
comprehensive radiation oncology program. Their
expertise and dedication has built DMG’s radiation
oncology into a strong and highly rated program
that complements all aspects of our Integrated
Oncology Program.Radiation ONCOLOGY
The American Society for Laser Medicine and Surgery, Inc. (ASLMS) has
developed a program called New Beginnings: Radiation Mark Removal
Program. This is a national, philanthropic campaign aimed at removing
radiation treatment marks free of charge to cancer patients. DMG board
certified dermatologists who are among only 100 other board certified
ASLMS members across the United States providing this service.
RADIATION TATTOO REMOVAL PROGRAM
Breast Services As the first to offer 3D mammography, or
tomosynthesis, in the western suburbs, DMG
has continued its commitment to breast services.
When new locations are acquired, we continue
to upgrade equipment to offer patients enhanced
imaging options for screening and diagnostic
mammograms. With our recent expansion,
we now offer these options at our Tinley Park
location.
Additional breast services available include
wire localization procedures, stereotactic
biopsy, MRI diagnostic breast exams, MRI
guided breast biopsies, breast ultrasound and
lymphoscintigraphy. Additionally, DMG Breast
Centers in Naperville, Lisle, Hinsdale and Joliet
have been designated as Breast Imaging Centers
of Excellence by the American College of
Radiology.
PET/CT DMG has two stationary PET/CT scanners to
provide imaging services in the western and south
suburbs. Scanners provide whole body imaging
for most oncological indications and PET/CT
bone scans to evaluate metastatic bone disease.
NETSPOT will help locate tumors in adult and
pediatric patients with somatostatin receptor-
positive neuroendocrine tumors.
Nuclear Medicine General nuclear medicine procedures are offered
at our Lisle, Naperville and Blue Island locations.
Both the Lisle and Blue Island locations offer
therapeutic procedures using I-131 therapy
to treat cancer and other medical conditions
affecting the thyroid gland. In Lisle and Naperville,
we offer lymphoscintigraphy procedures that
allow surgeons to locate which lymph node a
tumor drains to first. This lymph node is identified
as the sentinel node and the procedure provides
information for breast cancer and melanoma
staging.
Interventional Radiology Radiology launched the new Interventional
Radiology (IR) program in August 2017. IR uses
advanced imaging technology to perform
minimally invasive procedures in the care and
comfort of our outpatient radiology centers.
Often times IR can perform procedures that are
less invasive, more cost-effective and safer, with
less recovery time when compared to traditional
methods. Our board certified IR physicians and
staff will be a valuable new asset to our current
Integrated Oncology program.
The first phase of our IR program includes services
such as biopsy, PleurX catheter placement,
paracentesis and thoracentesis. Later phases of
our IR program will include oncologic treatments
such as radioembolization and tumor ablation.
IR procedures are initially being offered at our
centers in Glen Ellyn and Tinley Park, and select
ultrasound procedures are available at our
Naperville imaging center.
RadiologyDMG boasts some of the most state-of-the-art
diagnostic imaging capabilities in the Chicago
area, offering a complete spectrum of leading-
edge technology and specialized clinical expertise.
All DMG radiologists are board certified as well as
subspecialized, which means they have advanced
expertise, training and improved clinical accuracy
to help ensure correct results are provided to
guide patient care. DMG radiology sites have
earned national accreditation from the American
College of Radiology (ACR).
Low-dose protocols have also been put into
place to ensure that patients receive the right
dose and minimize radiation exposure while
maintaining diagnostic quality imaging. We know
that advanced imaging is crucial to providing the
right cancer treatment, which is why we continue
to evolve and invest in our offerings. In an effort
to provide access and increased convenience to
patients, diagnostic imaging appointments are
available seven days a week with extended hours.
MRI DMG has both 1.5T and 3.0T imaging capabilities.
MRI services are now offered at eight locations
throughout our service area. As new MRI scanners
are added, DMG has selected “wide bore” models,
which have broadened the demographics of
patients who may be tested and provides
greater patient comfort. DMG currently has
wide bore MRI scanners in Bloomingdale,
Glen Ellyn, Hinsdale and Lisle. DMG also
offers advanced MRI imaging techniques
such as cholangiography, MR spectroscopy,
Whole-body diffusion-weighted MRI and
multi-parametric MRI prostate exams.
Low-Dose CT DMG radiology has been designated as a
Lung Cancer Screening Center through the
ACR. All CT locations are accredited and
meet the requirements specified by Centers
for Medicare and Medicaid Services to perform
low-dose computed tomography (LDCT) for
Medicare-eligible members who meet certain
criteria. This testing is also available for consumers
with commercial insurance or on a self-pay basis.
DMG provides patients with comprehensive breast
services, from screening and diagnosis to treatment
of breast cancer. DMG’s screenings and diagnostic
breast services include: clinical breast exams and
education, screening and diagnostic digital/3D
mammography, diagnostic MRI breast imaging,
breast ultrasound,and breast biopsy (ultrasound,
stereotactic, MRI and excisional).
Since the inception of our cancer program, breast
cancer has been a focus because it accounts for the
largest percentage of cancer cases at DMG. DMG
is focused on providing the very best in care and
utilization of state-of-the-art screening equipment to
facilitate patient care. 3D mammography is the gold
standard in breast imaging and first line of defense
in detecting breast cancer. DMG was proud to be
the first to offer 3D mammography in the western
suburbs, and today, nearly all DMG locations
offering breast screenings are equipped with 3D
mammography.
In 2017, DMG performed more than 60,000
mammograms. To emphasize the importance of
regular screenings and to encourage patients
to stay up-to-date with their screenings, yearly
mammogram reminders are emailed to patients
when they are due for their exams. For added
convenience, current DMG patients do not need
a primary care physician’s order to schedule a
screening mammogram. Patients can also utilize
online scheduling for their screening mammogram,
making access to care easier than ever
before. Utilizing our internal radiology
services, DMG patients are able to
complete their screening and as a result,
receive a seamless transition of care
between diagnostic testing and
their physicians.
October is National Breast Cancer Awareness
Month. In honor of this, DMG providers offer
free clinical breast exams and provide patient
education and high-risk assessments. In 2017,
DMG offered free clinical breast exams on nine
dates spanning October and November with both
morning and afternoon options available at three
of our convenient locations in Glen Ellyn, Lisle and
Naperville.
If a patient is diagnosed with cancer, DMG provides
an array of treatment options including surgery,
radiation therapy and chemotherapy, as well as
advanced breast reconstruction or plastic surgery
following treatment. DMG’s breast surgeons are
sub-specialized and highly trained in the latest
techniques relating to breast surgery. These
surgeons have the patient’s best interest in mind
and aim to offer breast-conserving procedures
whenever possible. They are also trained in lymph
node-related procedures to evaluate the spread
of disease. During 2017, DMG surgeons performed
approximately 770 including 255 mastectomies and
432 lumpectomies.
BREAST CANCER
High Risk Breast Clinic DMG’s High Risk Breast Clinic was developed to
treat individuals who are at a high risk or genetic
predisposition of developing breast cancer. This
team provides comprehensive breast cancer
screening, genetic risk evaluation, genetic testing
and counseling services. During an appointment
in the High Risk Breast Clinic, a patient goes
through a detailed personal and family history.
Based on that information, genetic testing may be
recommended to further evaluate their risk. DMG’s
High Risk Breast Clinic gained an additional breast
nurse navigator in 2017 to provide further support
to our patients. The two breast nurse navigators
oversee this program, along with a licensed genetic
counselor through our partnership with Myriad®.
3D MAMMOGRAPHY 3D mammography, also known as breast
tomosynthesis, is an exciting advancement in
the screening and diagnosis of breast cancer
that allows radiologists to see breast tissue in
more detail than ever before. A 3D scan allows
radiologists to view breast tissue one layer
at a time. Rather than one flat, dense image,
radiologists can examine breast tissue in one-
millimeter layers, making it easier to interpret
any abnormalities.
By compiling these layers into a 3D model,
radiologists are able to see a more complete
picture of a patient’s breast health, which helps
to better detect cancer and reduces reporting of
false positives. DMG continues to increase access
to 3D mammography. Most recently, this service
was introduced in Tinley Park with plans to add
this offering at future locations.
herDMG Exams In 2014, DMG launched the “herDMG” initiative to
meet the needs of our busy female patients by
offering an all-inclusive, age-specific preventive
exam scheduled through a single phone call.
Each herDMG visit includes a wellness exam,
clinical breast exam, pelvic exam with pap test,
routine blood work, and screening mammogram
for patients 40 years and older (unless determined
to be high-risk, requiring an earlier baseline
mammogram). Additional blood work for chronic
disease monitoring and management may also be
completed during a herDMG visit.
In 2015, DMG expanded this program to all primary
care and OB/GYN physicians. Since its launch,
the herDMG program has grown to perform more
than 45,000 herDMG wellness exams per year.
The program continues to provide a clear clinical
benefit to the well-being of our female patients
and helps DMG meet preventive care benchmarks,
which have become increasingly important in the
evolving value-based healthcare arena.
Advanced Breast Reconstruction DMG plastic surgeons offer a full spectrum of breast
reconstruction options using the most innovative
surgical techniques. Having trained at some of
the most elite institutions, these leaders in the
field of plastic surgery offer both implant breast
reconstruction as well as breast reconstruction
using a patient’s own tissue. Not only were our
plastic surgeons one of the visionaries of the
prepectoral implant reconstruction technique
using implants, they now teach this technique to
plastic surgeons across the country. Prepectoral
breast reconstruction with an implant reduces
postoperative complications such as muscle
animation deformity and enhances the overall
aesthetics of the reconstruction.
In 2016, DMG expanded its breast reconstruction
treatment options to offer state-of-the-art micro-
surgery. As an alternative, plastic surgeons can
perform deep inferior epigastric perforator (DIEP)
flap reconstruction using the patient’s own tissue.
This technique spares the patient’s abdominal
muscles and creates a natural-appearing breast for
patients who are not candidates for breast implants.
Radiation therapy administered within 1 year (365 days) of diagnosis for women under age 70 who received breast conservation surgery (BCSRT) Tamoxifen or third generation aromatase inhibitor is considered or administered within 1 year (365 days) of diagnosis for women with AJCC T1cN0M0, stage IB - stage III hormone receptor positive breast cancer (HT) Radiation therapy is considered or administered following any mastectomy within 1 year (365 days) of diagnosis of breast cancer for women with ≥ 4 positive regional lymph nodes (MASTRT)
Image or palpation-guided needle biopsy (core or FNA) of the primary site is performed to establish diagnosis ofbreast cancer nBx - (breast needle bx)
Performance Measures for Breast Cancer Monitored by Commission on Cancer
ACCOUNTABILITY MEASURES | RATE 90%
QUALITY IMPROVEMENT MEASURES | RATE 80%
DMG CONCORDANCE
100
100
100
100
Evidence-based measures or accountability measures promote improvements in care delivery and are
the highest standard for measurement. These measures demonstrate provider accountability and promote
transparency. The table below illustrates DMG’s ongoing commitment to achieve these quality measures and
provide the highest level of care for our patients. These quality metrics are reviewed quarterly and shared with
the cancer committee. DMG is in full compliance with the national quality metrics, which provide our patients
with the confidence they are receiving the highest quality of care available.
Robotic SurgeryRobotic surgery is the most progressive form of
minimally invasive surgery available today. DMG
is proud to offer one of the most advanced and
comprehensive robotic programs in the region.
DMG’s Robotic Surgery Program offers a wide
range of procedures performed by more than 25
robotically-skilled surgeons working across multiple
specialties, including general surgery, gynecology,
otolaryngology (ENT) and urology. DMG surgeons
have expertise in numerous robotic procedures,
including several complex cancer-related surgeries.
Using the da Vinci® Surgical System, surgeons
accomplish delicate and complex operations
through just a few tiny incisions with the help of
increased vision, precision, dexterity and control.
With its stereoscopic, 3D imaging and precision-
guided wrist movements, the robotic-assisted
system allows surgeons to combine the best of
laparoscopy and regular open surgery techniques.
Transoral Robotic Surgery (TORS)
A DuPage Medical Group
otolaryngologist and member
of the Integrated Oncology
Program is currently one of
the only surgeons performing
Transoral Robotic Surgery
(TORS) in the Chicago area.
The minimally invasive TORS
procedure involves removing
tumors located in the throat, the
base of the tongue or the tonsils,
but with the benefits of quicker
recovery time, no visible scarring
or incisions and limited blood
loss during surgery.
Robotic-Assisted Cystectomy Surgery
DMG urologic oncologists
are performing leading-edge,
robotic cystectomy surgery as
a minimally invasive option for
bladder cancer treatment. This
procedure involves removing
part, or all, of the bladder,
lymph node dissection and
urinary diversion through
small keyhole incisions. While
surgical cystectomy cases in
the Chicagoland area are still
predominantly performed by
opening the abdominal cavity,
DMG surgeons are making
minimally invasive surgical
options more widely available in
the suburbs.
Successful Removal of Large Kidney Tumor
A DuPage Medical Group
urologist and member of the
Integrated Oncology Program
performed the successful
removal of a patient’s complex,
football-sized kidney tumor using
da Vinci® robotic technology
after several other non-DMG
surgeons said it couldn’t be
done laparoscopically. Not only
did he remove the massive
tumor, but also the entire right
kidney through an incision similar
in size to a C-section incision.
This innovative approach
provided the patient a smaller
and more discreet scar, and
allowed her to return home only
three days later and resume
crossfit six weeks post-surgery.
robotics program accomplishmentsDMG’s expertise in urologic and colorectal robotic procedures is unsurpassed and one of the few programs
in the area offering robotic cystectomy. Robotic surgery is particularly effective over traditional surgery when
performing more challenging procedures. Notable accomplishments in our robotics program include:
160
140
120
100
80
60
40
20
0
0-2
9
1
30
-39
8
40
-49
92
50
-59
140
60
-69
160
70-7
9
108
80
-89
32
90
+
5
Age at Breast Cancer Diagnosis Statistics | 2016
N = 546 Range = 28-92 Mean = 61
DMG provides a multidisciplinary
approach throughout the continuum
of care for patients diagnosed with
genitourinary cancer.
With cancer screening being an important aspect
to every patient’s care, DMG developed the Men’s
Health Clinic in order to provide comprehensive,
accessible care for all aspects of men’s health,
including prostate health and cancer screening.
Along with this program we have also added a
Prostate/Bladder Cancer Support group and a Men’s
Health Rehab Service for post-surgical support.
DMG primarily uses the following tests/examinations
for prostate cancer: prostate specific antigen
(PSA), digital rectal exam (DRE), 4KScore, genomic
and genetic testing and multi-parametric MRI of
the prostate, F18 Sodium Fluoride PET Bone Scan
and F18 Axumin PET/CT. Additionally, testing for
bladder and kidney cancer can include rectal/
vaginal examination, urine tests, CT scan or MRI,
PET/CT scan, F18 Sodium Fluoride PET Bone scan,
or cystoscopy and biopsy. Epigenetic testing is also
used.
Our multidisciplinary team meets bi-monthly to
review cases related to genitourinary diseases/
conditions. Our team takes into account many
factors when developing individualized care
plans including the stage of cancer, overall health
and ability to withstand therapy. Depending on
screening results, DMG urologists may recommend
active surveillance (prostate cancer), surgery,
chemotherapy, radiation therapy or a combination
of methods.
Genitourinary CANCER
advancing urologic cancer carein the community
DMG has two fellowship-trained urologic
oncology sub-specialists who are highly
trained in state-of-the-art techniques and
procedures for cancer care. They offer
advanced robotic surgery for prostate cancer
(nerve-sparing prostatectomy), bladder
cancer (robotic radical cystectomy and
robotic urinary diversion) and kidney cancer
(robotic partial nephrectomy and radical
nephrectomy).
As most surgical cystectomy cases in the
Chicagoland area are performed by opening
the abdominal cavity to remove part of the
bladder, DMG held a medical education
event for other local urologists and medical
professionals. There, the fellowship-trained
urologists taught attendees about the
oncologic efficacy of performing robotic
cystectomy based on current literature in
an effort to create awareness of robotic
cystectomies available in the suburban area.
DMG urologic oncologists are some of the
busiest in the region, making them well-
versed in these complex procedures and
leaders in their field. For recurrent prostate
cancer, salvage prostate cryotherapy
(cryoablation) is also available as an
alternative to hormone treatment as long
as the cancer has not spread beyond the
prostate.
180
160
140
120
100
80
60
40
20
0STAGE I STAGE II STAGE III STAGE IV
Prostate Cancer by Stage at Diagnosis
95
182
42 48
In 2016, 371 new prostate cancer cases were diagnosed.
Radiation
Surgery
Surgery, Radiation & other
Active surveillance
ADT/RAD
ADT alone
Patient refused treatment
85
75
67
63
32
31
18
Treatment modality administered
4
unknown
The gastrointestinal (GI) program was formalized in
2015 and provides a fully comprehensive approach
to GI cancer, beginning with screening, through
diagnosis and treatment.
Although colorectal cancer is the third most
commonly diagnosed cancer in the US, screening
rates for colorectal cancer are currently below the
national goal. While progress has been made, in
2010, 59% of people eligible for screening reported
having received colorectal cancer testing.
In an effort to increase patient awareness and
educate patients on the importance of screening
for colorectal cancer, DMG initiated a patient
outreach initiative. Colorectal screening information
and colorectal test kits were sent to approximately
2,000 DMG patients who are considered at a higher risk for colorectal cancer due to risk factors and age.
DMG is also working to make preventive
gastrointestinal cancer services more accessible
by adding free-standing endoscopy centers
in Oakbrook Terrace and Warrenville in 2016.
Through the 2017 acquisition of Northwest Health
Care Associates, a third free standing facility
was added in Hoffman Estates to serve the north
suburbs. On average, DMG performs more than
16,000 colonoscopies each year with an adenoma
detection rate of 42%.
DMG uses a variety of testing to find
gastrointestinal cancers, including fecal occult
blood test, stool DNA test, colonoscopy,
sigmoidoscopy, CT colonography and double-
contrast barium enemas. Under the leadership of an
interventional gastroenterologist, radiofrequency
ablation (RFA) and endoscopic mucosal resection
(EMR) are also available for appropriate patients.
Gastrointestinal Services
If colorectal cancer is detected, a variety of surgical treatments are available. Surgical treatment options available at DMG include:
Transanal SurgeryTransanal surgery has been used for many decades
to remove growths within the rectum. This approach
is minimally invasive, helps patients avoid an
abdominal surgery and is able to preserve rather
than remove much of the rectum, which helps to
preserve bowel function.
Transanal Endoscopic Microsurgery (TEM)Transanal endoscopic microsurgery (TEM) has
differences which provide advantages over the
transanal surgery. TEM uses a closed tube system
to stretch the rectum open with air to provide
greater visibility and allows for larger growths to
be removed. Through the use of a small camera,
increased vision of the rectum lining is achieved for
growth removal. The camera can be placed close
to the growth, at an angle or magnified, enhancing
precision and visibility through the entire length of
the rectum.
Transanal Mimimally Invasive Surgery (TAMIS)Transanal minimally invasive surgery (TAMIS) is
one of the newest techniques in treating polyps
and early-stage rectal cancer. TAMIS is a minimally
invasive procedure and a hybrid of several different
techniques that have been developed over many
years, first available in 2009. This hybrid approach
maintains the benefits of transanal surgery (minimally
invasive with rectum preservation) and adds the
benefits of TEM (enhanced visibility and further
reach into the rectum) while using conventional
laparoscopic instruments. The combination of a
transanal approach (with excellent visibility) along
with use of conventional instruments (ease of
learning technique and reduced cost) has made this
technique very popular and more widely utilized. It
is also leading to new techniques for rectal surgery,
such as transanal total mesorectal excision (taTME).
DMG is one of the few institutions in the area to offer
these advanced treatment options. Our surgeons
are specially trained in GI surgeries and provide full
surgical capabilities to treat cancer while trying to
preserve the patient’s quality of life. DMG continues
to expand its GI program and in the last year added
two more physicians to the team, fellowship-trained
in colon & rectal cancer surgery.
STAGE II28%
stage iii27%
STAGE I21%
stage iv22%
Colorectal cancer by stage at time of diagnosis
In 2016, 156 new colorectal cancer cases were diagnosed.
stage 02%
Cancer can develop in many locations in the head
and neck. The treatment of head and neck cancer
is complex, depending on the location, since it
can affect vital functions like breathing, speaking,
swallowing, hearing and smelling.
Currently, there is no screening method that
has proven to improve survival rates for those
with head and neck cancers. Because of this,
DMG encourages patients to complete a yearly
physical exam with their primary care provider
which includes a physical examination of the neck
and throat. Additionally, patients aged 9 to 26
are encouraged to get the Human Papillomavirus
(HPV) vaccine to prevent becoming infected with a
virus that may become cancerous.
Eighty-five percent of head and neck cancers
are linked to tobacco use, including smoking
or smokeless tobacco. DMG emphasizes the
importance of quitting smoking to reducing risk,
and provides smoking cessation resources to our
patients.
Identifying the cancer and determining if it has
spread, i.e. staging the cancer, is an important
first step to determining the right treatment. We
offer state-of-the-art diagnostic testing including
endoscopy, imaging (CT, PET/CT, MRI, chest X-ray,
ultrasound), fine needle aspiration and biopsy. Not
all cancers respond in the same way to treatment.
At DMG, we rely on the most current techniques in
molecular testing to evaluate cancer specimens.
These markers help us find the best treatment
for that cancer and allow us to provide accurate
prognostic information. We also obtain genetic
testing for those individuals who have cancers
with known familial associations.
Surgical techniques vary depending on the type
and location of cancer. Surgery may involve
minimally invasive, world-class, endoscopic and
robotic techniques. DMG otolaryngologists are
some of the few physicians in the Chicago area
trained in robot-assisted surgery for the head and
neck. Notably, we offer Transoral Robotic Surgery
(TORS) for the treatment of oral cancers to treat
tumors in the throat, base of the tongue and tonsils
that can be challenging to reach. Studies show
that Transoral Robotic Surgery (TORS) outcomes
result in swallowing and speech function that
is as good as or better than traditional surgical
methods. Some other associated benefits include
no visible scars, quicker recovery time and fewer
complications and risks of infection. With TORS
surgery, there is also a high probability that
no additional treatments will be needed. This
decreases the risk of injuring muscles used to
swallow and other nerves of the throat.
Surgical treatment for head and neck cancer
may be combined with reconstructive surgery,
chemotherapy or radiation therapy (external beam
or brachytherapy). All treatments are focused on
preserving as much appearance, speech, taste
and swallowing function as possible.
Head & Neck CANCER
The hepatopancreatobiliary (HPB) program at
DMG provides a comprehensive approach to the
diagnosis and treatment of benign and malignant
diseases of the liver, gallbladder, bile ducts,
pancreas and duodenum.
Regarding HPB cancers, they are some of the most
complex and challenging cancers to treat because
their incidence is relatively low, there are no reliable
screening tests, symptoms generally emerge in
the late stages and they are often very aggressive.
Our physicians employ a wide variety of techniques
including state-of-the-art diagnostic imaging and
advanced endoscopic interventions to investigate
symptoms, ascertain and diagnose, and plan
treatment as expeditiously as possible.
For instance, our multidisciplinary HPB team employs
a variety of tests to help diagnose HPB cancers
including blood tests, trans-abdominal ultrasound,
Upper endoscopy and endoscopic ultrasound (EUS)
with fine-needle aspiration (FNA), CT or MRI, and
Endoscopic Retrograde Cholangiopancreatography
(ECRP) with cholangioscopy or pancreatoscopy
for direct visualization of the bile and pancreatic
duct. To further assist with staging and treatment
planning, PET/CT scan is also available.
Many patients will require several different types
of treatment including chemotherapy, surgery
and radiation therapy. Our multidisciplinary team
convenes monthly to discuss our challenging HPB
cancer cases and achieve consensus on the type and
timing of treatment to offer.
Our surgeons who specialize in HBP cancers are
experts in surgical resections and have access to
world-class equipment for open, laparoscopic
and robot-assisted surgery. Minimally invasive and
laparoscopic methods, including intraoperative
ultrasound and ablation techniques that use
microwaves or radiofrequency to burn tumors, are
also leading-edge techniques available for HBP
treatment.
While surgery is the mainstay in treatment for
HPB cancers, radiation therapy and systemic
chemotherapy are also available as adjuncts
to surgery or when surgery is not feasible or
appropriate.
Pancreatic, Liver, Biliary (HPB)
Thyroid cancer is the most commonly diagnosed
endocrine cancer and the fastest increasing cancer
(by new diagnoses) in both men and women.
DMG is committed to prevention, diagnosis and
treatment of all endocrine cancers including thyroid,
parathyroid, adrenal, pancreatic, pituitary, testicular
and ovarian tumors.
The comprehensive thyroid cancer program takes
a collaborative approach among subspecialists
to create a personalized treatment plan. This plan
addresses not only the disease, but also the patient
experience, to ensure all questions are answered
and every treatment option is discussed and
explored. We help our patients understand the
importance of their family history and risk factors for
an endocrine-related malignancy. Our staff educates
patients about avoiding unnecessary exposure to
radiation as well as endocrine-disrupting and/or
carcinogenic compounds.
We believe that excellent treatment refers to the
technical aspects of medicine and surgery and in
the way we guide patients through that process.
Our care team works tirelessly to ensure patients
understand each step in their care and who to
contact when questions arise.
thyroid cancer
Thyroid cancer by genderIn 2016, 112 new thyroid cancer cases were diagnosed
Male
female
localized
14
66
regional
12
18
Today, the outlook for someone diagnosed with
lung cancer is better than ever, due to the advances
in screening and treatment. Patients with a heavy
smoking history who meet certain requirements fall
into a high-risk group where preventive screening is
recommended. DMG has multiple radiology locations
that offer low-dose CT. Through this screening process,
we are able to detect cancers when they are small and
have not spread throughout the body.
Based on the diagnostic results, the multidisciplinary
team is able to optimize therapy and individualize
the course of treatment for a patient. State-of-the-
art radiation therapies and cutting-edge surgical
techniques are also available. In 2017, DMG added
two new pulmonologists to the team and now offers
pulmonary services in Joliet to provide increased
access to care in the south suburbs.
Lung Cancer Statistics | 2016175 new lung cancer diagnoses made in 2016
Lung CANCER
The earlier a cancer can be diagnosed, the easier
it is to treat. That is why DMG offers low-dose
lung CT (LDCT) scans, which diagnose lung
cancer at an early stage. LDCT scans are the
recommended screening test for lung cancer
by the United States Preventative Services Task
Force and the leading method for early detection
of lung cancer, especially in high-risk patients.
LDCT exams are recommended for those who meet the following guidelines:
Are between the age of 55 and 77 and are either current smokers or have quit smoking within the past 15 years.
Have a tobacco smoking history of at least 30 pack years, which is at least a pack a day for 30 years. (If a person smoked 2 packs a day for 15 years that equals 30 pack years.)
Obtain a written order from a qualified medical provider.
LUNG CANCER SCREENING
Lung Cancer
by Stage at
Diagnosis
Lung Cancer
by Type
Small cell carcinoma
16%
Non-small cell carcinoma
84%
distant
1
1
DMG pulmonary specialists use innovative
strategies such as endobronchial ultrasound
bronchoscopy (EBUS) in diagnosing lung cancer.
EBUS is a minimally invasive procedure used in the
diagnosis and staging of lung cancer and other
diseases causing enlarged lymph nodes in the
chest. EBUS is less invasive than older methods,
provides real-time imaging and lets the physician
easily view “difficult-to-reach” areas.
Pulmonary specialists also routinely use advanced
bronchoscopic techniques such as electromagnetic
navigational bronchoscopy and radial probe
endoscopic ultrasonography to biopsy peripheral
lung nodules. Navigational bronchoscopy can
also be used to place fiducial markers used in
stereotactic body radiation therapy.
DMG also offered smoking cessation classes to
support patients in their efforts to quit smoking
as a first line of defense against lung cancer.
In 2016, the DMG Integrated Oncology Program
added new quality measures for its Lung Cancer
Program to ensure we are providing patients with
the highest level of quality care.
DMG has monitored these metrics quarterly and
is in full compliance with national standards. The
table below highlights DMG’s commitment to
providing our lung cancer patients with the best care
possible.
Non-Small Cell Lung – Quality Improvement Measure – Rate 85%
Systemic chemotherapy is administered within 4 months to day preoperatively or day of surgery to 6 months postoperatively, or it is recommended for surgically resected cases with pathologic, lymph node-positive (pN1) and (pN2) NSCLC (LCT)
Surgery is not the first course of treatment for cN2, M0 lung cases LNoSurg
DMG Concordance %
100%
100%
coc measures for quality cancer care
STAGE II11%
stage iii25%
STAGE I28%
stage iv36%
While DMG has been diagnosing and treating
skin and soft tissue cancer for many years, 2017
marks the second year for our formal skin & soft
tissue cancer program to ensure that care is
provided consistently across our growing system
of providers. Through this program, we have
launched cancer conferences that provide patients
with an internal second opinion and consensus
from a multidisciplinary team.
DMG dermatologists focus a large part of their
patient care on skin cancer screening and
prevention. As a part of preventive care, DMG’s
medical spas sell a variety of physician-grade
sunscreen products to best protect patients
from the harmful sun rays. Dermatologists also
recommend yearly skin exams and routinely offer
them to various community groups to help find
cancer at the earliest stage possible.
Skin cancer is diagnosed by a physical exam-
ination and biopsy. Through a biopsy, all or part
of the suspicious spot is removed and sent to a
laboratory. Diagnostic tests to identify soft tissue
sarcoma include X-ray, CT or MRI, ultrasound,
PET/CT scan or biopsy. Skin/soft tissue cancer
treatment plans are individualized, and factor in
the stage of cancer, the patient’s overall health
and ability to tolerate therapy. Treatment options
may include biopsy, surgery, chemotherapy,
immunotherapy and radiation therapy.
Detecting CancerIn 2017, DMG launched an “Ugly Duckling”
campaign to help increase patient awareness
on the importance of performing self-skin spot
checks as well as the warning signs of skin
cancer. The Ugly Duckling Method follows the
traditional “A, B, C, D, E” guidelines for checking
moles and skin lesions:
• A is for Asymmetry
• B is for Border irregularity
• C is for Color differences within a mole
• D is for Diameter greater than 6 mm or a pencil eraser head
• E is for Evolution or changing moles
• F is for Family history of melanoma in a first-degree relative
Skin & Soft Tissue CANCER
Mohs Surgery DMG has dermatologists who are specially trained
in Mohs surgery to provide the highest level of
care to patients. Mohs surgery is accepted as the
single most effective technique for removing basal
cell carcinoma and squamous cell carcinoma.
Physicians are able to spare the greatest amount of
healthy tissue while almost completely removing
cancer cells. Cure rates reach more than 98
percent with Mohs surgery.
Histology Lab At DMG’s Histology Lab, providers review the
structure and tissue of samples to determine if
cells are cancerous or contain other diseases. The
Histology Lab of DuPage Medical Group has been
accredited by the College of American Pathologists
(CAP), which is a significant achievement that
speaks to the quality provided to patients in
need of histology services.
90
80
70
60
50
40
30
20
10
0STAGE 0 STAGE I STAGE II STAGE Iii
malignant melanoma Diagnosis by stage | 2016(185 total cases)
70
90
13 10
2
STAGE Iv
Genetic Testing – Prostate CancerFor patients with known or suspected familial
disorders, blood can be tested to help determine
the presence of a specific genetic abnormality. This
can help in screening family members as well as
providing prognostic information. DMG urologists
utilize epigenetic testing, including OncotypeDx,
Prolaris, ConfirmMDx and Decipher for prostate
cancer screening.
TelegeneticsIn partnership with Myriad, DMG launched a
telegenetics program offering genetics testing
and free genetic counseling to patients on
Tuesdays and Thursdays in our Winfield and Lisle
locations.The program provides patient education
and genetic counseling completed by a phone call
with an off-site Myriad® counselor.
Following the appointment, the genetic counselor
is able to electronically submit the testing
information and paperwork needed to obtain
the specimen and complete the tests being
ordered directly to the staff at the DMG site. A
member of the DMG clinical staff then collects the
specimen from the patient and sends it to Myriad®
to complete the testing. This process provides
high-risk and cancer patients access to genetic
counseling services and testing at a convenient
DMG site.
Online Scheduling
In a continued effort to provide easier and more
convenient access to our care, DMG continues to
expand upon our online scheduling capabilities.
In 2017, nearly all Integrated Oncology Program
providers, specialists and diagnostic services
began offering patients the ability to schedule
their appointments online.
In addition, patients being referred to the
Integrated Oncology Program are able to make an
appointment online utilizing a newly developed
electronic ticket system in MyChart. When
a referral is entered into MyChart, a ticket is
generated which allows the patient to use the
ticket to schedule their appointment online. Since
its launch, the system provides more convenient
scheduling for oncology patients. As many as 20
appointments are scheduled online through this
new system each week.
Resource Library The DMG Cancer Resource Library is located in the
Cancer Resource Center at the Lisle Medical Office
Building and includes educational materials about
cancer, treatment and symptom management for
patients, their families and caregivers.
Cancer Resources & SUPPORTDMG provides patients & their families with complimentary resources, support
and services to help in their fight against cancer.
Support Services DMG wellness programs are helpful for patients
and their families who face cancer. Our team
provides supportive care, classes, information and
reference materials. We partner with community
organizations, including the American Cancer
Society, LivingWell Cancer Resource Center,
Wellness House and the Cancer Support Center.
Oncology Social Work & Supportive Care Our licensed clinical social worker helps patients
identify practical and psycho-social needs and
directs individuals to the appropriate supportive
care resources. Our social worker is available at any
point in the cancer continuum - from the point of
diagnosis through survivorship - and can provide a
wide array of support including counseling, educa-
tion, family support and transportation assistance.
Our social worker is an integral part of the care
team and works closely with a patient’s medical
team, patients, family and caregivers.
As part of our pledge to patient-centered care,
we recognize our patients have more than just
physical needs to be addressed throughout their
cancer treatment. We assess these needs through
a comprehensive distress screening process, based
on NCCN guidelines. Currently, DMG social workers
are averaging 270 distress screenings per month.
Our patients and their families can be confident
that our support extends to them beyond just
their physical diagnosis and treatment plan.
Groups, Classes & Services Our ongoing classes are designed to support the
mind, body and soul, and are a key part of the
integrated approach to cancer care. Below are
a few of our offerings:
ART THERAPY Art classes using various art mediums are offered
through Wellness House at DuPage Medical Group.
NUTRITION WORKSHOPSNutrition workshops offered by a registered
dietitian help patients learn how to optimize their
diet and manage some of the effects of cancer
treatment and aid in recovery.
AMERICAN CANCER SOCIETY LOOK GOOD … FEEL BETTER™ Beauty professionals help female cancer patients
cope with the physical and emotional effects
of cancer treatment during a complimentary
workshop held monthly at our Lisle location and
quarterly at our Tinley Park location. To date in
2017, the program has provided support to 36
patients.
SMOKING CESSATION A four-week program focused on overcoming
nicotine addiction was offered in both the
west and south suburbs.
PROVIDER(S)
Surgery Department Providers
DMG-Wide Initiative
Shraddha Desai, MDCara Bushemi, PA-CChris Kelly, PA-C
Chris Kelly, PA-C
Shruthi Reddy, MDShraddha Desai, MDChris Arico, PA-CChris Kelly, PA-CCara Bushemi, PA-C
Stephanie Gan, MDAndrea Rutherford, PA-C
Melissa Koopmann PA-CSarah McCracken PA-CBridget Padgett PA-C
TOTAL RECIPIENTS
8 patients screened, 2 referred for genetic counseling, 1 referred to the high risk breast clinic, 1 referred to follow up with a breast surgeon.
Test kits & screening information was sent to approximately 2,000 patients
79 White Sox office staff & player personnel (8 were recommended for biopsy)
38 participants at the Carillon Health Fair (10 were recommended for biopsy)
20 DMG employees screened for Melanoma Monday (none referred for biopsies)
18 DMG employees screened for Melanoma Monday (5 referred for biopsies)
19 DMG employees screened for Melanoma Monday (5 referred for biopsies)
SCREENING TYPE
Free Clinical Breast Exams
Colorectal Cancer Screening
Skin Cancer Screening
Skin Cancer Screening
Skin Cancer Screening
Skin Cancer Screening
Skin Cancer Screening
DATE
Oct - Nov 2017
9/30/2017
8/24/2017
6/14/2017
5/1/2017
5/1/2017
5/1/2017
SCREENINGS Screening tests are the best way to help find cancer at an early stage, many times before symptoms appear.
DMG is committed to its employees and the community, which is why we continuously provide routine cancer
screenings throughout the year.
Survivorship DMG has a survivorship program for patients during
their treatment and after treatment has concluded.
The survivorship program’s goal is to give survivors
the information, tools and support they need to move
forward after cancer treatment.
The primary tool is an individualized, comprehensive
end-of-treatment summary that includes: a detailed
description of all the treatments received from
diagnosis onward; notes of what to watch out for
in years to come; probable complications; long-term
treatment; and healthy steps and interventions that
are recommended in the future.
This Survivorship Care Plan, along with an in-person
meeting with an Advanced Practice Provider helps
patients transition from active cancer treatment
to follow-up and surveillance. The summary is sent
to the patient’s primary care physician who may
have had limited participation in the treatment
regimen once the cancer was diagnosed. The care
plan empowers patients to take control through
knowledge and resources that help them embrace
this phase of their health after cancer treatment.
The DMG Integrated Oncology Advisory Board is
an invaluable forum for idea sharing and planning,
that ensures DMG is providing patient-centered
care, communication and supportive services to
its patients and families, while identifying areas of
opportunity. The Advisory Board provides patients
with the opportunity to engage in open dialogue
with DMG Oncology Program leaders to discuss
overall cancer care, both in the community and at
DMG. In 2017, the Advisory Board addressed some
of the important areas of patient care: diagnosis and
preparation for treatment, nurse navigation, support
services, cancer survivor day and use of technology
to communicate with healthcare providers.
financial navigation Finances are often a major concern for patients
dealing with a cancer diagnosis. Meeting with a
financial navigator can help lead to peace of mind
about medical expenses and allow patients to focus
on their recovery. Services provided include estimates
for future treatments, copays and deductibles based
on diagnosis and chosen treatment, assistance with
bills and claims issues, understanding insurance
benefits and obligations, patient assistance
program applications, and help for patients who are
underinsured or have no insurance in finding assistance.
Even more attention was placed on our financial
navigators in 2017 with the creation of additional
patient resources to help direct patients to financial
navigators who are available in person, by phone and
on a walk-in basis to assist our patients at locations in
Lisle and Tinley Park.
American Cancer Society Wig Boutique DMG has partnered with the American Cancer Society
to provide on-site, complimentary wigs and wig
fittings with a trained wig boutique volunteer at our
Lisle location. To date in 2017, 75 wigs were provided
at no charge to cancer patients.
To date, by partnering with the ACS, DMG has been
able to provide access to additional support and
resources to 150 patients through the Wig Boutique,
Look Good Feel Better program and the Road to
Recovery program, which provides patients with
transportation to and from treatment free of charge.
patient ADVISORY BOARD
DMG provided grants totaling more than $150,000 in 2017 to various partners, including:
• DuPage Health Coalition’s Silver Access Plan
• Dispensary of Hope Pharmacy
• Wellness House
• Living Well Cancer Resource Center
• Close the Gap Campaign
• FORWARD Initiative
• Relay for Life
• Making Strides Against Breast Cancer
• American Cancer Society Share the Drive Campaign
DMG participated in and sponsored a variety of community-based events in 2017 as well, including:
• June 2017 Cancer Survivor Day Sponsor
• June 2017 Relay for Life: DMG staff members participated by forming a team to walk and raised
over $14,000 for this event. DMG also served as a flagship sponsor.
• October 2017 Making Strides Against Breast Cancer: DMG staff formed a team to walk and served as a flagship event sponsor as well as a photo booth sponsor for the Orland Park event in our expanded south region.
Community OUTREACH DMG physicians and staff show their commitment to the communities we serve by providing educational talks,
volunteering at community events and supporting philanthropic initiatives.
PROVIDER(S)
Viveka Boddipalli, MDSurehka Boddipalli, MD
Amit Patel, MDRanko Miocinovic, MDTom Beris, MD
Amit Patel, MD
Katie Driessens, RNLara Hamilton, RD
Chris Arico, PA
Kim Warren, APN
Daniel Frank, MD
Chris Arico, PA
Daniel Frank, MDAnand Shah, MD
Karl Napekoski, MDAmit Patel, MD
Dawn Williams, LCSW
Amit Patel, MDRanko Miocinovic, MD
Viveka Boddipalli, MD
TOTAL RECIPIENTS
Developments in lung cancer treatment & management recommendations
CME Presentation on Advanced Robotic Surgery
Updates in Bladder Cancer
Foods that Fight Cancer
Sun Protection & Skin Cancer Prevention
Heart Health after Cancer Hot Topics in Breast Cancer - Medical Oncology Updates
Sun Protection & Skin Cancer Prevention
Head & Neck Cancer Treatment and Management
Update on Pathologic Prostate Cancer Staging and Gleason Grade Grouping
Strengthening Relationships
Hot Topics in Prostate Cancer -Recurrence Developments in Lung Cancer Treatment & Management Recommendations
SCREENING TYPE
Wellness House
DMG sponsored at the Le Meridian Hotel in Oakbrook
Wellness House
American Cancer Society
NICOR employee lunch & learn
Living Well Men’s Breakfast
Wellness House
Diabetes Support Group
Wellness House
DMG Annual CME Presentation for Providers & Staff
Cancer Support Center Survivor Camp
Wellness House
Wellness House
DATE
2/02/17
3/16/17
4/25/17
4/26/17
6/6/17
6/17/17
6/24/17
7/19/17
8/24/17
9/12/17
9/16/17
9/23/17
12/14/17
Educational PRESENTATIONS Expertise. Knowledge. Experience. These are just a few of the reasons DMG’s team of healthcare leaders and
innovators are in demand as speakers and presenters. Below is a list of our community presentations in 2017:
CANCER COMMITTEE 2017Brian J. Moran, MD - Committee Chair
Anand Shah, MD - (Alternate) Committee Chair, Radiation Oncology
Janet Chin, MD - Cancer Liaison Physician
Saadia Yunus, DO - (Alternate) Cancer Liaison Physician, Medical Oncology
Amrit Mangat, MD, FACS - Surgery
Ciaran Bradley, MD, MA - (Alternate) Surgery
Jonathan Nolan, MD - Radiology
Nasir Siddiqui, MD - (Alternate) Radiology
Richard Anderson, MD - Pathology
Karl Napekoski, MD - (Alternate) Pathology
Loren Baer, MHA, CMA (AAMA) - Cancer Program Administrator
Theresa Levigne, RT(N), CNMT, MBA - (Alternate) Cancer Program Administrator, Radiology Senior Manager
Misbah Baggia, CTR, RHIT - Cancer Registry Quality Coordinator
Achiamma George, CTR, RHIA - (Alternate) Cancer Registry Quality Coordinator
Kathryn Wieser, RN, BSN, OCN, MBA - Nurse Leadership
Jessica Fiehler, RN, BSN, OCN - (Alternate) Nurse Leadership
Dawn Williams, LCSW, CADC - Psychosocial Service Coordinator
Melissa Petty, M. Ed, LCPC - (Alternate) Psychosocial Service Coordinator
Daniel Grzegorek, DO - Palliative Care
Matthew Baugh, MD - (Alternate) Palliative Care, Pulmonary
Rameez Alasadi, MD - Gastroenterology
David Wolraich, MD - Otolaryngology
Amit R. Patel, MD - Urology
Stephanie Gan, MD - Dermatology
Yoojim Kim Pak, MD - Endocrinology
Kathy Omerod, APN, AOCN, CBCN - Nurse Navigator
Trai Le, MS, DABR - Physicist- Radiation Oncology
Haley Goulson, PA-C - Survivorship Care
Peri Todd - Clinical Research Coordinator
Elizabeth Bludgen - Rehabilitation Services
Nitika Agarwal, PharmD, MBA - Pharmacy
Debbie Fager - American Cancer Society